Literature DB >> 25269542

Visualization and characterization of cancer stem-like cells in cervical cancer.

Kazuhiko Hayashi1, Keisuke Tamari1, Hideshi Ishii2, Masamitsu Konno3, Naohiro Nishida3, Koichi Kawamoto3, Jun Koseki2, Takahito Fukusumi3, Yoshihiro Kano3, Shimpei Nishikawa3, Masaaki Miyo3, Kozo Noguchi3, Hisataka Ogawa3, Atsushi Hamabe3, Yuji Seo1, Yuichiro Doki3, Masaki Mori3, Kazuhiko Ogawa1.   

Abstract

Cancer stem cells (CSCs), defined by their differentiation capacity, self-renewal capacity, and maintenance of proliferation, have been identified in many tumors, including cervical cancer. Current studies identify CSCs by several specific biomarkers; however, it is difficult to monitor cervical CSCs in real-time in vitro and in vivo. Recent research reported the visualization of CSCs in breast cancer and gliomas using green fluorescent protein, ZsGreen, fused to a degron motif ornithine decarboxylase (ODC), which is destroyed by proteasomes. Accordingly, CSCs have low 26S proteasome activity, whereas non-CSCs have high 26S proteasome activity. Therefore, it is possible to observe CSCs by their accumulation of the fluorescent ZsGreen protein. In this study, we investigated optical imaging parameters to evaluate CSCs using two human cervical cancer cell lines: CaSki and HeLa. We defined populations as cell types having high- and low ZsGreen-cODC (high- and low-Zs, respectively) expression levels. The results of a sphere-forming assay revealed that the self-renewal ability of the high-Zs population was significantly higher than that of the low-Zs population. A tumorigenicity assay confirmed that the high-Zs population exhibited higher tumorigenic potential than the low-Zs population. The radioresistance of the high-Zs population of both HeLa and CaSki cells and the chemoresistance of the high-Zs population of CaSki cells were confirmed by a clonogenic survival assay and the tetrazolium dye assay, respectively. These results indicate that high-Zs populations of both the HeLa and CaSki cell lines possess CSC-like properties and therapeutic resistance. In conclusion, we successfully visualized CSC-like cells using a fluorescent protein system.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25269542     DOI: 10.3892/ijo.2014.2670

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  13 in total

1.  The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma.

Authors:  Kruttika Bhat; Mohammad Saki; Erina Vlashi; Fei Cheng; Sara Duhachek-Muggy; Claudia Alli; Garrett Yu; Paul Medina; Ling He; Robert Damoiseaux; Matteo Pellegrini; Nathan R Zemke; Phioanh Leia Nghiemphu; Timothy F Cloughesy; Linda M Liau; Harley I Kornblum; Frank Pajonk
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-01       Impact factor: 11.205

2.  Cancer stem cells don't waste their time cleaning-low proteasome activity, a marker for cancer stem cell function.

Authors:  Kristiaan J Lenos; Louis Vermeulen
Journal:  Ann Transl Med       Date:  2016-12

3.  Mebendazole Potentiates Radiation Therapy in Triple-Negative Breast Cancer.

Authors:  Le Zhang; Milana Bochkur Dratver; Taha Yazal; Kevin Dong; Andrea Nguyen; Garrett Yu; Amy Dao; Michael Bochkur Dratver; Sara Duhachek-Muggy; Kruttika Bhat; Claudia Alli; Frank Pajonk; Erina Vlashi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-09-07       Impact factor: 7.038

4.  PK-M2-mediated metabolic changes in breast cancer cells induced by ionizing radiation.

Authors:  Le Zhang; Justine Bailleul; Taha Yazal; Kevin Dong; David Sung; Amy Dao; Laura Gosa; David Nathanson; Kruttika Bhat; Sara Duhachek-Muggy; Claudia Alli; Milana Bochkur Dratver; Frank Pajonk; Erina Vlashi
Journal:  Breast Cancer Res Treat       Date:  2019-08-01       Impact factor: 4.872

5.  Radiation-Induced Dedifferentiation of Head and Neck Cancer Cells Into Cancer Stem Cells Depends on Human Papillomavirus Status.

Authors:  Erina Vlashi; Allen M Chen; Sabrina Boyrie; Garrett Yu; Andrea Nguyen; Philip A Brower; Clayton B Hess; Frank Pajonk
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-01-14       Impact factor: 7.038

Review 6.  Methionine metabolism in health and cancer: a nexus of diet and precision medicine.

Authors:  Sydney M Sanderson; Xia Gao; Ziwei Dai; Jason W Locasale
Journal:  Nat Rev Cancer       Date:  2019-09-12       Impact factor: 60.716

7.  A Trans-omics Mathematical Analysis Reveals Novel Functions of the Ornithine Metabolic Pathway in Cancer Stem Cells.

Authors:  Jun Koseki; Hidetoshi Matsui; Masamitsu Konno; Naohiro Nishida; Koichi Kawamoto; Yoshihiro Kano; Masaki Mori; Yuichiro Doki; Hideshi Ishii
Journal:  Sci Rep       Date:  2016-02-11       Impact factor: 4.379

Review 8.  Getting to the heart of the matter in cancer: Novel approaches to targeting cancer stem cells.

Authors:  Hugh Colvin; Masaki Mori
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2017       Impact factor: 3.493

9.  Targeting poor proteasomal function with radioiodine eliminates CT26 colon cancer stem cells resistant to bortezomib therapy.

Authors:  Jin Hee Lee; Kyung-Ho Jung; Jin Won Park; Seung Hwan Moon; Young Seok Cho; Kyung-Han Lee
Journal:  Sci Rep       Date:  2020-08-31       Impact factor: 4.379

10.  Polyamine flux suppresses histone lysine demethylases and enhances ID1 expression in cancer stem cells.

Authors:  Keisuke Tamari; Masamitsu Konno; Ayumu Asai; Jun Koseki; Kazuhiko Hayashi; Koichi Kawamoto; Noriyuki Murai; Senya Matsufuji; Fumiaki Isohashi; Taroh Satoh; Noriko Goto; Shinji Tanaka; Yuichiro Doki; Masaki Mori; Kazuhiko Ogawa; Hideshi Ishii
Journal:  Cell Death Discov       Date:  2018-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.